Six major pharmaceutical firms, including Dr. Reddy’s Laboratories, Aurobindo Pharma, and Hetero Labs, have signed agreements with the Telangana government to set up operations in the state’s Pharma City. These companies will invest more than Rs 5,260 crore, creating around 12,490 jobs in the pharmaceutical sector, according to a government statement.
Representatives from the companies met with Chief Minister A. Revanth Reddy and Industries Minister D. Sridhar Babu at the Secretariat to finalize the agreements. The investments will fund the establishment of various manufacturing units and research facilities in the recognized Pharma City.
The companies involved include MSN Laboratories, which will build a manufacturing unit and R&D center; Laurus Labs and Aurobindo Pharma, both planning formulation units; and Gland Pharma, which will open an R&D center along with facilities for injectables and drug substance production. Additionally, Dr. Reddy’s Labs will develop an injectable and biosimilars unit, while Hetero Labs will set up a manufacturing plant for finished doses and injectables.
The Chief Minister has directed officials to allocate land for these new facilities and ensure that the necessary infrastructure is in place, with construction set to begin in the next four months. Telangana Pharma City is an ambitious industrial hub dedicated to the pharmaceutical and life sciences sectors, located near Hyderabad, India. It is being developed as a world-class facility with state-of-the-art infrastructure to support the growth of the pharmaceutical industry.
The city is designed to house manufacturing plants, research and development centers, and allied industries, creating a conducive environment for innovation and high-quality production. With a focus on sustainable development, Telangana Pharma City is set to play a pivotal role in India’s pharmaceutical manufacturing and export capabilities. The initiative aims to attract both domestic and international investments, providing significant employment opportunities and contributing to the region’s economic growth. With its strategic location and well-developed infrastructure, the city is poised to become a global hub for the pharmaceutical industry.
